Table 2 Spearman correlation of serum p-tau231 and p-tau181 with CSF biomarkers in cohort 3
From: Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Serum p-tau231 | Serum p-tau181 | |
|---|---|---|
CSF Aβ42, pg/ml | rho= -0.55; P=0.0006 | rho= -0.66; P<0.0001 |
CSF total-tau, pg/ml | rho=0.62; P<0.0001 | rho= 0.73; P<0.0001 |
CSF p-tau181 (Innotest), pg/ml | rho=0.55; P=0.0006 | rho= 0.67; P<0.0001 |
CSF p-tau181 (Simoa), pg/ml | rho=0.57; P=0.0003 | rho= 0.71; P<0.0001 |
CSF p-tau231 (Simoa), pg/ml | rho = 0.56; P=0.0004 | rho= 0.70; P<0.0001 |
Serum p-tau231, pg/ml | - | rho=0.93, P<0.0001 |
Serum p-tau181, pg/ml | rho=0.93, P<0.0001 | - |